Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Molecular mechanisms and therapeutic targets of inflammatory-related Cardiovascular diseases: from molecular mechanisms to therapeutic targets.

Sardu C, Paolisso G, Marfella R.

Curr Pharm Des. 2020 Feb 13. doi: 10.2174/1381612826666200213123029. [Epub ahead of print]

PMID:
32053065
2.

Metformin: An old drug against old age and associated morbidities.

Salvatore T, Pafundi PC, Morgillo F, Di Liello R, Galiero R, Nevola R, Marfella R, Monaco L, Rinaldi L, Adinolfi LE, Sasso FC.

Diabetes Res Clin Pract. 2020 Jan 16;160:108025. doi: 10.1016/j.diabres.2020.108025. [Epub ahead of print] Review.

PMID:
31954752
3.

Strengths and Opportunities of Network Medicine in Cardiovascular Diseases.

Benincasa G, Marfella R, Della Mura N, Schiano C, Napoli C.

Circ J. 2020 Jan 24;84(2):144-152. doi: 10.1253/circj.CJ-19-0879. Epub 2019 Dec 21.

4.

The dating of thrombus organization in cases of pulmonary embolism: an autopsy study.

Mansueto G, Costa D, Capasso E, Varavallo F, Brunitto G, Caserta R, Esposito S, Niola M, Sardu C, Marfella R, Napoli C, Paternoster M.

BMC Cardiovasc Disord. 2019 Nov 8;19(1):250. doi: 10.1186/s12872-019-1219-8.

5.

Metformin lactic acidosis: Should we still be afraid?

Salvatore T, Pafundi PC, Marfella R, Sardu C, Rinaldi L, Monaco L, Ricozzi C, Imbriani S, Nevola R, Adinolfi LE, Sasso FC.

Diabetes Res Clin Pract. 2019 Nov;157:107879. doi: 10.1016/j.diabres.2019.107879. Epub 2019 Oct 13. Review.

PMID:
31618624
6.

Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin.

Sardu C, D'Onofrio N, Torella M, Portoghese M, Loreni F, Mureddu S, Signoriello G, Scisciola L, Barbieri M, Rizzo MR, Galdiero M, De Feo M, Balestrieri ML, Paolisso G, Marfella R.

Cardiovasc Diabetol. 2019 Sep 30;18(1):126. doi: 10.1186/s12933-019-0931-0.

7.

Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study.

Sasso FC, Pafundi PC, Gelso A, Bono V, Costagliola C, Marfella R, Sardu C, Rinaldi L, Galiero R, Acierno C, Caturano A, de Sio C, De Nicola L, Salvatore T, Nevola R, Adinolfi LE, Minutolo R; NO BLIND Study Group.

Nutr Metab Cardiovasc Dis. 2019 Sep;29(9):923-930. doi: 10.1016/j.numecd.2019.05.065. Epub 2019 Jun 7.

PMID:
31377186
8.

MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients.

D'Onofrio N, Sardu C, Paolisso P, Minicucci F, Gragnano F, Ferraraccio F, Panarese I, Scisciola L, Mauro C, Rizzo MR, Mansueto G, Varavallo F, Brunitto G, Caserta R, Tirino V, Papaccio G, Barbieri M, Paolisso G, Balestrieri ML, Marfella R.

J Cell Physiol. 2020 Feb;235(2):1438-1452. doi: 10.1002/jcp.29064. Epub 2019 Jul 11.

PMID:
31294459
9.

Genetic and epigenetic-sensitive regulatory network in immune response: a putative link between HLA-G and diabetes.

Sommese L, Benincasa G, Schiano C, Marfella R, Grimaldi V, Sorriento A, Lucchese R, Fiorito C, Sardu C, Nicoletti GF, Napoli C.

Expert Rev Endocrinol Metab. 2019 Jul;14(4):233-241. doi: 10.1080/17446651.2019.1620103. Epub 2019 May 27.

PMID:
31131681
10.

Cardiac syncope recurrence in type 2 diabetes mellitus patients vs. normoglycemics patients: The CARVAS study.

Sardu C, Paolisso P, Santamaria M, Sacra C, Pieretti G, Rizzo MR, Barbieri M, Scisciola L, Nicoletti G, Paolisso G, Marfella R.

Diabetes Res Clin Pract. 2019 May;151:152-162. doi: 10.1016/j.diabres.2019.04.015. Epub 2019 Apr 18.

PMID:
31004672
11.

Prior β-blocker treatment decreases leukocyte responsiveness to injury.

Grisanti LA, de Lucia C, Thomas TP, Stark A, Strony JT, Myers VD, Beretta R, Yu D, Sardu C, Marfella R, Gao E, Houser SR, Koch WJ, Hamad EA, Tilley DG.

JCI Insight. 2019 Mar 28;5. pii: 99485. doi: 10.1172/jci.insight.99485.

12.

High HDL cholesterol: A risk factor for diabetic retinopathy? Findings from NO BLIND study.

Sasso FC, Pafundi PC, Gelso A, Bono V, Costagliola C, Marfella R, Sardu C, Rinaldi L, Galiero R, Acierno C, de Sio C, Caturano A, Salvatore T, Adinolfi LE; NO BLIND Study Group.

Diabetes Res Clin Pract. 2019 Apr;150:236-244. doi: 10.1016/j.diabres.2019.03.028. Epub 2019 Mar 20.

PMID:
30904748
13.

Abdominal Fat SIRT6 Expression and Its Relationship with Inflammatory and Metabolic Pathways in Pre-Diabetic Overweight Patients.

D'Onofrio N, Pieretti G, Ciccarelli F, Gambardella A, Passariello N, Rizzo MR, Barbieri M, Marfella R, Nicoletti G, Balestrieri ML, Sardu C.

Int J Mol Sci. 2019 Mar 6;20(5). pii: E1153. doi: 10.3390/ijms20051153.

14.

Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study.

Sasso FC, Pafundi PC, Marfella R, Calabrò P, Piscione F, Furbatto F, Esposito G, Galiero R, Gragnano F, Rinaldi L, Salvatore T, D'Amico M, Adinolfi LE, Sardu C.

Cardiovasc Diabetol. 2019 Mar 4;18(1):24. doi: 10.1186/s12933-019-0826-0.

15.

Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study.

Sardu C, Paolisso P, Sacra C, Mauro C, Minicucci F, Portoghese M, Rizzo MR, Barbieri M, Sasso FC, D'Onofrio N, Balestrieri ML, Calabrò P, Paolisso G, Marfella R.

Diabetes Care. 2019 Oct;42(10):1946-1955. doi: 10.2337/dc18-2356. Epub 2019 Feb 22.

PMID:
30796109
16.

Thrombus Aspiration in Hyperglycemic Patients With High Inflammation Levels in Coronary Thrombus.

Sardu C, D'Onofrio N, Mauro C, Balestrieri ML, Marfella R.

J Am Coll Cardiol. 2019 Feb 5;73(4):530-531. doi: 10.1016/j.jacc.2018.10.074. No abstract available.

17.

Circulating MiRNA-195-5p and -451a in Transient and Acute Ischemic Stroke Patients in an Emergency Department.

Giordano M, Ciarambino T, D'Amico M, Trotta MC, Di Sette AM, Marfella R, Malatino L, Paolisso G, Adinolfi LE.

J Clin Med. 2019 Jan 22;8(2). pii: E130. doi: 10.3390/jcm8020130.

18.

Correction to: Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up.

Sardu C, Barbieri M, Balestrieri ML, Siniscalchi M, Paolisso P, Calabrò P, Minicucci F, Signoriello G, Portoghese M, Mone P, D'Andrea D, Gragnano F, Bellis A, Mauro C, Paolisso G, Rizzo MR, Marfella R.

Cardiovasc Diabetol. 2018 Dec 27;17(1):159. doi: 10.1186/s12933-018-0804-y.

19.

Telemedicine for screening diabetic retinopathy: The NO BLIND Italian multicenter study.

Sasso FC, Pafundi PC, Gelso A, Bono V, Costagliola C, Marfella R, Sardu C, Rinaldi L, Galiero R, Acierno C, de Sio C, Adinolfi LE; NO BLIND Study Group.

Diabetes Metab Res Rev. 2019 Mar;35(3):e3113. doi: 10.1002/dmrr.3113. Epub 2019 Jan 7.

PMID:
30548967
20.

Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up.

Sardu C, Barbieri M, Balestrieri ML, Siniscalchi M, Paolisso P, Calabrò P, Minicucci F, Signoriello G, Portoghese M, Mone P, D'Andrea D, Gragnano F, Bellis A, Mauro C, Paolisso G, Rizzo MR, Marfella R.

Cardiovasc Diabetol. 2018 Nov 29;17(1):152. doi: 10.1186/s12933-018-0795-8. Erratum in: Cardiovasc Diabetol. 2018 Dec 27;17(1):159.

21.

Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes.

Sasso FC, Rinaldi L, Lascar N, Marrone A, Pafundi PC, Adinolfi LE, Marfella R.

J Diabetes Res. 2018 Oct 4;2018:3106056. doi: 10.1155/2018/3106056. eCollection 2018. Review.

22.

Letter by Sardu et al Regarding Article, "Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy".

Sardu C, Paolisso G, Marfella R.

Circulation. 2018 Aug 28;138(9):954-955. doi: 10.1161/CIRCULATIONAHA.118.034725. No abstract available.

PMID:
30354453
23.
24.

Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients.

Sardu C, Pieretti G, D'Onofrio N, Ciccarelli F, Paolisso P, Passavanti MB, Marfella R, Cioffi M, Mone P, Dalise AM, Ferraraccio F, Panarese I, Gambardella A, Passariello N, Rizzo MR, Balestrieri ML, Nicoletti G, Barbieri M.

Front Physiol. 2018 Aug 21;9:1030. doi: 10.3389/fphys.2018.01030. eCollection 2018.

25.

ELectrophysiological mechanisms underlying the Inhibitory CArdiac syncope without asystolic significant pause: Therapeutic and prognostic implications. The ELICA randomized trial.

Sardu C, Marfella R, Testa G, Santamaria M, Sacra C, Ranauro A, Paolisso G, Rizzo MR, Barbieri M.

Medicine (Baltimore). 2018 Aug;97(31):e11757. doi: 10.1097/MD.0000000000011757.

26.

Stretch, Injury and Inflammation Markers Evaluation to Predict Clinical Outcomes After Implantable Cardioverter Defibrillator Therapy in Heart Failure Patients With Metabolic Syndrome.

Sardu C, Marfella R, Santamaria M, Papini S, Parisi Q, Sacra C, Colaprete D, Paolisso G, Rizzo MR, Barbieri M.

Front Physiol. 2018 Jun 26;9:758. doi: 10.3389/fphys.2018.00758. eCollection 2018.

27.

Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis.

Marfella R, Sardu C, Balestrieri ML, Siniscalchi M, Minicucci F, Signoriello G, Calabrò P, Mauro C, Pieretti G, Coppola A, Nicoletti G, Rizzo MR, Paolisso G, Barbieri M.

Diabetol Metab Syndr. 2018 Jan 3;10:1. doi: 10.1186/s13098-017-0304-3. eCollection 2018.

28.

Serum adiponectin levels are associated with worse cognitive function in postmenopausal women.

De Franciscis P, Barbieri M, Leo S, Dalise AM, Sardu C, Marfella R, Colacurci N, Paolisso G, Rizzo MR.

PLoS One. 2017 Dec 21;12(12):e0186205. doi: 10.1371/journal.pone.0186205. eCollection 2017.

29.

Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: Effects of incretin treatment.

Marfella R, Sardu C, Calabrò P, Siniscalchi M, Minicucci F, Signoriello G, Balestrieri ML, Mauro C, Rizzo MR, Paolisso G, Barbieri M.

Diabetes Obes Metab. 2018 Mar;20(3):723-729. doi: 10.1111/dom.13122. Epub 2017 Nov 3.

PMID:
28950045
30.

Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes.

Sardu C, Barbieri M, Santamaria M, Giordano V, Sacra C, Paolisso P, Spirito A, Marfella R, Paolisso G, Rizzo MR.

Cardiovasc Diabetol. 2017 Jun 9;16(1):75. doi: 10.1186/s12933-017-0554-2.

31.

Nasotracheal prolonged safe extubation in acute respiratory failure post-thyroidectomy: An efficacious technique to avoid tracheotomy? A retrospective analysis of a large case series.

Ferraro F, Gambardella C, Testa D, Santini L, Marfella R, Fusco P, Lombardi CP, Polistena A, Sanguinetti A, Avenia N, Conzo G.

Int J Surg. 2017 May;41 Suppl 1:S48-S54. doi: 10.1016/j.ijsu.2017.03.082.

32.

[Diabetes mellitus and atrial fibrillation: evidence of a pathophysiological, clinical and epidemiological association beyond the thromboembolic risk].

Proietti R, Russo V, Wu MA, Maggioni AP, Marfella R.

G Ital Cardiol (Rome). 2017 Mar;18(3):199-207. doi: 10.1714/2674.27397. Review. Italian.

PMID:
28398378
33.

Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome.

Sardu C, Santamaria M, Funaro S, Sacra C, Barbieri M, Paolisso P, Marfella R, Paolisso G, Rizzo MR.

Medicine (Baltimore). 2017 Apr;96(14):e6558. doi: 10.1097/MD.0000000000006558.

34.

Effects of Alpha Lipoic Acid on Multiple Cytokines and Biomarkers and Recurrence of Atrial Fibrillation Within 1 Year of Catheter Ablation.

Sardu C, Santulli G, Santamaria M, Barbieri M, Sacra C, Paolisso P, D'Amico F, Testa N, Caporaso I, Paolisso G, Marfella R, Rizzo MR.

Am J Cardiol. 2017 May 1;119(9):1382-1386. doi: 10.1016/j.amjcard.2017.01.040. Epub 2017 Feb 10.

35.

123I-MIBG Scintigraphy in the Subacute State of Takotsubo Cardiomyopathy.

Sardu C, Sacra C, Mauro C, Siniscalchi M, Marfella R, Rizzo MR.

JACC Cardiovasc Imaging. 2017 Jan;10(1):93-94. doi: 10.1016/j.jcmg.2016.07.016. No abstract available.

36.

Incretin treatment and atherosclerotic plaque stability: Role of adiponectin/APPL1 signaling pathway.

Barbieri M, Marfella R, Esposito A, Rizzo MR, Angellotti E, Mauro C, Siniscalchi M, Chirico F, Caiazzo P, Furbatto F, Bellis A, D'Onofrio N, Vitiello M, Ferraraccio F, Paolisso G, Balestrieri ML.

J Diabetes Complications. 2017 Feb;31(2):295-303. doi: 10.1016/j.jdiacomp.2016.10.001. Epub 2016 Oct 5.

37.

Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study.

Sasso FC, Lascar N, Ascione A, Carbonara O, De Nicola L, Minutolo R, Salvatore T, Rizzo MR, Cirillo P, Paolisso G, Marfella R; NID-2 study group.

Cardiovasc Diabetol. 2016 Oct 13;15(1):147.

38.

Glycemic control and acute coronary syndrome: the debate continues.

Marfella R, Paolisso G.

Eur Heart J Cardiovasc Pharmacother. 2015 Oct;1(4):229-31. doi: 10.1093/ehjcvp/pvv027. Epub 2015 Jun 1. No abstract available. Erratum in: Eur Heart J Cardiovasc Pharmacother. 2016 Oct;2(4):217.

PMID:
27532446
39.

Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART Study.

Sardu C, Santamaria M, Rizzo MR, Barbieri M, di Marino M, Paolisso G, Santulli G, Marfella R.

Int J Clin Pract. 2016 Jul;70(7):569-76. doi: 10.1111/ijcp.12823. Epub 2016 Jun 13.

40.

Sarcopenia in Elderly Diabetic Patients: Role of Dipeptidyl Peptidase 4 Inhibitors.

Rizzo MR, Barbieri M, Fava I, Desiderio M, Coppola C, Marfella R, Paolisso G.

J Am Med Dir Assoc. 2016 Oct 1;17(10):896-901. doi: 10.1016/j.jamda.2016.04.016. Epub 2016 Jun 2.

PMID:
27262494
41.

Ergothioneine oxidation in the protection against high-glucose induced endothelial senescence: Involvement of SIRT1 and SIRT6.

D'Onofrio N, Servillo L, Giovane A, Casale R, Vitiello M, Marfella R, Paolisso G, Balestrieri ML.

Free Radic Biol Med. 2016 Jul;96:211-22. doi: 10.1016/j.freeradbiomed.2016.04.013. Epub 2016 Apr 19.

PMID:
27101740
42.

Author's reply.

Sardu C, Siniscalchi M, Sasso A, Mauro C, Paolisso G, Marfella R.

J Cardiol. 2016 Jul;68(1):89-90. doi: 10.1016/j.jjcc.2015.11.003. Epub 2016 Feb 15. No abstract available.

43.
44.

Awaking Blood Pressure Surge and Progression to Microalbuminuria in Type 2 Normotensive Diabetic Patients.

Barbieri M, Rizzo MR, Fava I, Sardu C, Angelico N, Paolisso P, Abbatecola A, Paolisso G, Marfella R.

J Diabetes Res. 2016;2016:5876792. doi: 10.1155/2016/5876792. Epub 2015 Dec 28.

45.

Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes.

Sardu C, Barbieri M, Rizzo MR, Paolisso P, Paolisso G, Marfella R.

J Diabetes Res. 2016;2016:7292564. doi: 10.1155/2016/7292564. Epub 2015 Nov 9. Review.

46.

Author's reply.

Siniscalchi M, Sardu C, Sasso A, Marfella R, Paolisso G, Mauro C.

J Cardiol. 2016 Jun;67(6):573. doi: 10.1016/j.jjcc.2015.09.023. Epub 2015 Nov 21. No abstract available.

47.

microRNA expression changes after atrial fibrillation catheter ablation.

Sardu C, Santamaria M, Paolisso G, Marfella R.

Pharmacogenomics. 2015 Nov;16(16):1863-77. doi: 10.2217/pgs.15.117. Epub 2015 Nov 10. Review.

PMID:
26554530
48.

Increased Arterial Stiffness Trumps on Blood Pressure in Predicting Cognitive Decline in Low-Risk Populations.

Marfella R, Paolisso G.

Hypertension. 2016 Jan;67(1):30-1. doi: 10.1161/HYPERTENSIONAHA.115.06450. Epub 2015 Nov 2. No abstract available. Erratum in: Hypertension. 2016 Apr;67(4):e6.

PMID:
26527047
49.

Effects of α-lipoic acid therapy on sympathetic heart innervation in patients with previous experience of transient takotsubo cardiomyopathy.

Marfella R, Barbieri M, Sardu C, Rizzo MR, Siniscalchi M, Paolisso P, Ambrosino M, Fava I, Materazzi C, Cinquegrana G, Gottilla R, Elia LR, D'andrea D, Coppola A, Rambaldi PF, Mauro C, Mansi L, Paolisso G.

J Cardiol. 2016 Feb;67(2):153-61. doi: 10.1016/j.jjcc.2015.07.012. Epub 2015 Sep 5.

50.

The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 Diabetes.

Capone F, Guerriero E, Colonna G, Maio P, Mangia A, Marfella R, Paolisso G, Izzo F, Potenza N, Tomeo L, Castello G, Costantini S.

PLoS One. 2015 Jul 30;10(7):e0134594. doi: 10.1371/journal.pone.0134594. eCollection 2015.

Supplemental Content

Loading ...
Support Center